CVS/pharmacy expands naloxone access in 12 more states

CVS/pharmacy announced Wednesday that it is expanding the availability of naloxone, providing the opioid overdose reversal drug without a prescription in 12 additional states. Previously, naloxone was available at CVS/pharmacy without a prescription in Rhode Island and Massachusetts.

CVS/pharmacy announced Wednesday that it is expanding the availability of naloxone, providing the opioid overdose reversal drug without a prescription in 12 additional states. Previously, naloxone was available at CVS/pharmacy without a prescription in Rhode Island and Massachusetts. However, the company is now also selling the drug without a prescription in Arkansas, California, Minnesota, Mississippi, Montana, New Jersey, North Dakota, Pennsylvania, South Carolina, Tennessee, Utah and Wisconsin. Noting the high death toll every year from accidental drug overdoses, Tom Davis, vice president of Pharmacy Professional Practices at CVS/pharmacy, said: "Naloxone is a safe and effective antidote to opioid overdoses, and by providing access to this medication in our pharmacies without a prescription in more states, we can help save lives." He added that while all CVS/pharmacy stores in the United States "can continue to order and dispense naloxone when a prescription is presented, we support expanding naloxone availability without a prescription and are reviewing opportunities to do so in other states." CVS Health is also participating in a research effort with Boston Medical Center and Rhode Island Hospital to support a demonstration project of pharmacy-based naloxone rescue kits, and CVS/pharmacy will continue with its Medication Disposal for Safer Communities Program, in which it is working with the Partnership for Drug-Free Kids to donate drug collection units to police departments nationwide.